This inventor holds 3 USPTO granted patents. Top assignee: Meiji Seika Kaisha, Ltd.. Active years: 2002-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2004
Title: Minoru Ishikawa: Innovator in Integrin Antagonists
Introduction
Minoru Ishikawa is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of integrin antagonists. With a total of 3 patents to his name, Ishikawa's work has the potential to impact various therapeutic areas.
Latest Patents
Ishikawa's latest patents include innovative compounds that demonstrate integrin antagonistic activity. His notable inventions are:
1. &OHgr;-amino-&agr;-hydroxycarboxylic acid derivatives having integrin &agr;&ngr;&bgr;3 antagonistic activity.
2. Phenylpiperazine derivatives as integrin &agr;v&bgr;3 antagonists.
Career Highlights
Minoru Ishikawa is currently employed at Meiji Seika Kaisha, Ltd., a company known for its commitment to research and development in the pharmaceutical industry. His work at the company has allowed him to focus on creating innovative solutions that address unmet medical needs.
Collaborations
Ishikawa has collaborated with esteemed colleagues such as Keiichi Ajito and Shoichi Murakami. Their combined expertise has contributed to the advancement of research in integrin antagonists.
Conclusion
Minoru Ishikawa's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile